Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 


Market Analyst
By the same author
More articles

Nissan, Altria, US job report: This Week's Top Trending Financial Tweets - Week 49

share with twitter share with LinkedIn share with facebook
share via e-mail
12/07/2018 | 10:46am EDT

Another week is coming to an end and what a week it's been again! We've got news about Nissan, Altria, the US job report and more, so here goes: this week's selection of top financial Tweets.

#7. Nissan recalls 150 000 vehicles

It’s safe to say that the past few weeks haven’t been great for Nissan. After the arrest of the car manufacturer’s ex-chairman Carlos Ghosn, Nissan now said it will recall 150 000 vehicles in Japan, the Financial Times reports.

The recall comes after ‘several newly found nonconformities that may have caused inaccurate pass/fail judgments during the inspection process.’

#6. Altria’s $1.8 billion investment

Marlboro cigarette maker Altria Group Inc has made a big bet on the fast-growing marijuana industry. The company invested $1.8 billion in Canadian cannabis producer Cronos Group Inc., Reuters reports.

The deal gives Altria a stake of up to 55% in Cronos and is the latest in a series of investments from consumer companies that are hoping to benefit from Canada’s move to legalize marijuana for recreational use, according to the same Reuters article.

#5. Chinese stocks down

Several Chinese stocks went down quite a bit on Thursday. The movement followed the arrest of Huawei’s Chief Financial Officer Meng Wanzhou in Vancouver, Canada, TechCrunch reports.

Canadian officials detained Meng because of suspicions of Huawei violating American sanctions on Iran. Shares of ZTE - Huawei’s main competitor - went down close to 6% in Hong Kong and those of Shennan Circuit, one of Huawei's suppliers dived almost 10% at some point.

#4. This year’s biggest biotech IPO

Moderna Inc. - a Massachusetts-based biotech firm - raised no less than $604 million in this year’s biggest initial public offering by a biotechnology company, Bloomberg reports.

According to the same Bloomberg article, Moderna doesn’t have any approved drugs (yet). The company expanded the size of the offering to sell almost 26.3 million shares at $23 per share. As such, the offering gives Moderna a market value at IPO of around $7.85 billion.

Further reading: Investing in Biotech: Five selection criteria

#3. US November job report

On Friday, there was the highly anticipated US job report for November. Although the report was not as good as expected, the US economy still added 155 000 jobs last month, CNN Business reports. The country’s unemployment rate remained stable, however, at 3.7%.

The report is reassuring for investors who were worried about the Fed moving too fast with its interest rate hikes.

#2. Oil up 5%

We already mentioned this week’s OPEC meeting in Vienna in last week’s overview, wondering if the cartel and non-cartel members would be able to come to an agreement.

It turns out they did.

On the OPEC side, Iran gave the cartel the green light on Friday to reduce the oil output by around 0.8 million barrels per day from 2019 onwards, Reuters reports.

On the non-OPEC side, it seems Moscow is ready to cut around 200 000 bpd and other non-OPEC countries could add another 200 000, which brings the grand total to 1.2 million bpd.

#1. South Africa introduces a minimum wage

Starting from the first of January 2019, South Africa will introduce a minimum wage. According to president Cyril Ramaphosa, the new legislation will force companies to pay their workers at least 20 rand ($1.42) per hour, Bloomberg reports.

Although this is still a very modest wage, it’s meant to provide an economic stimulus and help create jobs in a country where 27% of the labor force is unemployed, president Ramaphosa said.

And that's a wrap. As always, we’ll continue to track Twitter and bring you the top financial micro-messages from the web. See you back here next week.

Source: www.scoopnest.com.

Stocks mentioned in the article
ChangeLast1st jan.
VALUE8 2.51% 5.72 Delayed Quote.20.68%

Neelie Verlinden
© MarketScreener.com 2018
share with twitter share with LinkedIn share with facebook
share via e-mail